Kairos Pharma（KAPA.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他58.57%
个人与内部人士28.80%
机构投资者7.82%
私营企业4.81%

主要股东

主要股东最新
股东
John YuCEO, Chairman & Secretary	22.56%	76.38 万	2.41%	+0	2026/03/31
Technomedics Management & Systems, Inc	4.81%	16.27 万	0.51%	+0	2026/03/31
Neil BhowmickChief Scientific Officer	4.79%	16.22 万	0.51%	+0	2026/03/31
Armistice Capital LLC	3.73%	12.64 万	0.40%	+0	2025/06/30
Citadel Advisors LLC	1.31%	4.43 万	1.31%	+4.43 万	2026/06/30
Vanguard Capital Management, LLC	1.25%	4.22 万	0.13%	+0	2026/06/30
Ramachandran MuraliVice President of Research & Development	0.60%	2.03 万	0.06%	+0	2026/03/31
Douglas SamuelsonChief Financial Officer	0.59%	2.01 万	0.06%	+0	2026/03/31
Virtu Financial, Inc.	0.35%	1.17 万	0.35%	+1.17 万	2026/06/30
Geode Capital Management, LLC	0.33%	1.13 万	0.19%	-4,623.00	2026/06/30
Hyun BaeIndependent Director	0.21%	7,122.00	0.02%	+0	2026/03/31
SevenBridge Financial Group, LLC	0.19%	6,326.00	0.02%	+0	2026/06/30
Aptus Capital Advisors, LLC	0.19%	6,326.00	0.02%	+0	2026/06/30
Jane Street Group, LLC	0.14%	4,821.00	--	+4,821.00	2026/06/30
Susquehanna International Group, LLP	0.12%	4,184.00	--	+4,184.00	2026/06/30
State Street Investment Management	0.10%	3,442.00	0.01%	+0	2026/06/30
XTX Markets Limited	0.06%	2,131.00	0.06%	+2,131.00	2026/06/30
UBS Asset Management AG	0.03%	894.00	0.03%	+894.00	2026/06/30
Rahul SinghviIndependent Director	0.02%	796.00	<0.01%	+0	2026/03/31
Hansoo Michael KeyoungIndependent Director	0.02%	796.00	<0.01%	+0	2026/03/31